Fate Therapeutics Inc
NASDAQ:FATE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Fate Therapeutics Inc
NASDAQ:FATE
|
US |
|
L
|
Liberty Global PLC
NASDAQ:LBTYB
|
UK |
|
F
|
First America Resources Corp
OTC:FSTJ
|
US |
|
Spire Global Inc
F:EL9
|
US |
|
Fu Yu Corporation Ltd
SGX:F13
|
SG |
|
Caisse regionale de Credit Agricole Mutuel d'Ille-et-Vilaine
PAR:CIV
|
FR |
|
Anglogold Ashanti PLC
F:HT3
|
US |
|
Cementir Holding NV
F:3PC
|
IT |
|
C
|
China Properties Investment Holdings Ltd
HKEX:736
|
HK |
|
T
|
Techna-X Bhd
KLSE:TECHNAX
|
MY |
|
Nizhnekamskshina PAO
MOEX:NKSH
|
RU |
|
A
|
Apple Inc
XMUN:APC
|
US |
|
R
|
Recordati Industria Chimica e Farmaceutica SpA
SWB:RER1
|
IT |
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
US |
|
E
|
E79 Gold Mines Ltd
ASX:E79
|
AU |
|
KDB Tifa Finance Tbk PT
IDX:TIFA
|
ID |
Bankruptcy Probability
Fate Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Fate Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Fate Therapeutics Inc
NASDAQ:FATE
|
274.2m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
464.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
203.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
181.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
130.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
80B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
53.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
83.5B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
57.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
50.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
43.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Fate Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Fate Therapeutics Inc has total debt of 2.4m USD. This includes both short-term (0 USD) and long-term (2.4m USD) debt.
You can find a full breakdown on its Balance Sheet.